Skip to main content

Advertisement

Table 1 Baseline characteristics of participants with LVEF and outcomes (N = 445)

From: In-hospital measurement of left ventricular ejection fraction and one-year outcomes in acute coronary syndromes: results from the IMMEDIATE Trial

Variables Participants with neither death nor hospitalization for HF at 1 year N = 393 Participants with death or hospitalization for HF at 1 year N = 52
Age (mean ± SD, years) 61 ± 12.1 (393) 71 ± 13.0 (52)
Gender, % Male 75.6 (297) 69.2 (36)
White race (vs. non- White race) 86.7 % (341) 88.5 % (42)
Body Mass Index, (mean ± SD, units) 28.9 ± 6.3 (372) 27.9 ± 6.0 (42)
Time from onset of symptoms to treatment (minutes)   
 Mean ± SD, 146.8 ± 206.4 (353) 111.7 ± 109.3 (37)
 median < IQR > 78 < 50.0–140.0 > 65 < 40.0–145.0 >
Chief Complaint on Presentation   
 Chest Pain 91.8 % (361) 84.6 % (44)
Medical History, % (n)   
 CAD (MI, PCI or CABG) 30.8 % (121) 69.2 % (36)
 Heart Failure 6.7 % (25) 23.1 % (12)
 Diabetes Mellitus 21.1 % (83) 34.7 % (18)
 Hypertension 62.3 % (245) 78.8 % (41)
 Stroke 5.9 % (23) 15.4 % (8)
 Hyperlipidemia 46.8 % (184) 65.4 % (34)
Hospital Reperfusion Treatment, %(n)   
 PCI 73.8 % (290) 59.6 % (31)
 Thrombolytic therapy 0.8 % (3) 9.6 % (5)
 CABG 5.1 % (20) 7.7 % (4)
Confirmed Diagnosis, % (n)   
 Acute Myocardial Infarction 80.4 % (316) 78.8 % (41)
 Killip Class   
  1 76.1 % (299) 51.9 % (27)
  2 1.8 % (7) 1.3 % (7)
  3 0.5 % (2) 3.8 % (2)
  4 2.0 % (8) 9.6 % (5)
 Unstable Angina 12.7 % (50) 9.6 % (5)
ECG based findings   
 ST Elevation on Presentation (ECG) 70.8 % (264) 66.0 % (33)
 ACI-TIPI score, (Mean ± SD) 80.7 ± 17.6 (386) 84.8 ± 11.2 (49)
LVEF in %, Median (IQR) 50 (40,60) 35 (25,45)
GIK (vs. Placebo) 47.6 % (187) 38.5 % (20)